Cycurion's 1-for-8 Reverse Split Lifts Shares Off the Mat, but Can Financial Engineering Save a Sub-Dollar Stock?

Shares of Cycurion shifted sharply as the McLean, Virginia-based cybersecurity firm announced a 1-for-8 reverse stock split — a move that combines every eight existing shares into one — effective at market open on August 28. The stock bounced 11.2% to $0.51 in pre-market trading after cratering 29.5% on August 26, the day the split was disclosed. For investors, the question is whether this is a lifeline or a last resort.

• This Is the Second Reverse Split in Less Than a Year — and That's a Red Flag. Cycurion already executed a 1-for-30 reverse stock split on October 27, 2025. Now shareholders face another round of consolidation. The new split will shrink outstanding shares from roughly 25.8 million to about 3.2 million. Mathematically, at today's $0.51 price, the post-split price would land around $4.08 — above Nasdaq's $1.00 minimum but with little cushion if selling resumes.

• The Real Motive: Avoiding Being Kicked Off Nasdaq. On July 10, Nasdaq notified Cycurion that its stock had traded below the $1.00 minimum bid price for 31 consecutive business days, violating listing rules.

Because of the prior reverse split, the company was denied the usual 180-day grace period to fix the problem.

Cycurion requested a hearing before Nasdaq's panel, scheduled for August 20, and the reverse split is clearly part of its compliance pitch. Delisting would exile shares to thinly traded over-the-counter markets, devastating liquidity.

• The Business Has Contracts, but the Stock Tells a Darker Story. Cycurion recently won its largest-ever deal — a $54.6 million, 10-year government cybersecurity modernization contract.

It also closed an acquisition adding over $5 million in revenue. Yet the stock is down roughly 95% over the past year.

Q2 2026 earnings per share came in at -$0.41, beating estimates but still deeply negative. Revenue wins haven't translated into profitability.

• A Small Buyback Won't Move the Needle. Cycurion's board authorized a $500,000 share repurchase program on August 17. At current prices, that's a symbolic gesture — not a meaningful demand driver. Paired with management's earlier public rejection of a reverse split as a "cosmetic financial move," the reversal undercuts credibility. Investors should watch whether post-split trading holds above $1.00; if history is any guide, the odds aren't encouraging.